Carcinogenic viruses and solid cancers without sufficient evidence of causal association

International Journal of Cancer

Volumn 133, Issue 7, 2013, Pages 1517-1529

  De Paoli, Paolo ^a   Carbone, Antonino ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Epstein Barr virus; human papillomaviruses; JC virus; Merkel Cell virus; Mouse Mammary Tumor virus; solid cancers

Indexed keywords

HEPATITIS B VACCINE;

BREAST CANCER; BREAST CARCINOGENESIS; BURKITT LYMPHOMA; CANCER INCIDENCE; CANCER RISK; CAUSAL ATTRIBUTION; COLON CARCINOGENESIS; COLORECTAL CANCER; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; INCIDENCE; JC VIRUS; KAPOSI SARCOMA; LIVER CANCER; LIVER CELL CARCINOMA; LUNG CANCER; LUNG CARCINOGENESIS; MERKEL CELL POLYOMAVIRUS; MOUSE MAMMARY TUMOR ONCOVIRUS; NASOPHARYNX CARCINOMA; NONHUMAN; PAPILLOMAVIRUS INFECTION; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SOLID TUMOR; STOMACH CARCINOMA; TUMOR VIRUS; VACCINATION; VIRUS CARCINOGENESIS; VIRUS CELL INTERACTION; VIRUS INFECTION; WART VIRUS;

EPSTEIN BARR VIRUS; HUMAN PAPILLOMAVIRUSES; JC VIRUS; MERKEL CELL VIRUS; MOUSE MAMMARY TUMOR VIRUS; SOLID CANCERS;

ANIMALS; BREAST NEOPLASMS; CARCINOMA, MERKEL CELL; COLONIC NEOPLASMS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; LUNG NEOPLASMS; MAMMARY TUMOR VIRUS, MOUSE; MICE; PAPILLOMAVIRUS INFECTIONS; POLYOMAVIRUS INFECTIONS; RETROVIRIDAE INFECTIONS; TUMOR VIRUS INFECTIONS;

EID: 84880274048     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27995     Document Type: Review

References (128)

1. Boyle P, Levin B, eds. World Cancer Report. Lyon, France: World Health Organization, International Agency for Research on Cancer, 2008.
2. Zur Hausen H,. Infection causing human cancer. Weinheim: Wiley-VCH; Chichester: John Wiley 2006.
3. Clifford G, Franceschi S,. Immunity, infection, and cancer. Lancet 2007; 370: 6-7.
4. Parkin DM,. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006; 118: 3030-44.
5. Bouvard V, Baan R, Straif K, et al. A review of human carcinogens. Part B: biological agents. Lancet Oncol 2009; 10: 321-2.
6. IARC. Monographs on the Evaluation of Carcinogenic Risks to Humans. IARC Monogr. Eval. Carcinog. Risks Hum. Volume 100B, Biological Agents, Lyon, France, 2012.
7. Carbone A, De Paoli P,. Cancers related to viral agents that have a direct role in carcinogenesis: pathological and diagnostic techniques. J Clin Pathol 2012; 65: 680-6.
8. Hoppe-Seyler F, Hoppe-Seyler K,. Emerging topics in human tumor virology. Int J Cancer 2011; 129: 1289-99.
9. Javier RT, Butel JS,. The history of tumor virology. Cancer Res 2008; 68: 7693-706.
10. Cobbs CS,. Evolving evidence implicates cytomegalovirus as a promoter of malignant glioma pathogenesis. Herpesviridae 2011; 2: 10.
11. IARC. IARC monographs on the evaluation of carcinogenics risks to humans, Volume 70 (1997), Epstein-Barr virus and Kaposi's sarcoma herpesvirus/human herpesvirus 8. Lyon, France, 1997.
12. Carbone A, Gloghini A, Dotti G,. EBV-associated lymphoproliferative disorders: classification and treatment. Oncologist 2008; 13: 577-85.
13. Sousa H, Pinto-Correia AL, Medeiros R, Dinis-Ribeiro M,. Epstein-Barr virus is associated with gastric carcinoma: the questions is what is the significance? World J Gastroenterol 2008; 14: 4347-51.
14. Fukayama M, Hino R, Uozaki H,. Epstein-Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma. Cancer Sci 2008; 99: 1726-33.
15. Schulz TF,. The pleiotropic effects of Kaposi's sarcoma herpesvirus. J Pathol 2006; 208: 187-98.
16. Hengge UR, Ruzicka T, Tyring SK, et al. Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: pathogenesis, Castleman's disease, and pleural effusion lymphoma. Lancet Infect Dis 2002; 2: 344-52.
17. Kalt I, Masa Sr, Sarid R,. Linking the Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to human malignancies. Methods Mol Biol 2009; 471: 387-407.
18. Grulich AE, Van Leeuwent MT, Falster MO, et al. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007; 370: 59-67.
19. Carbone A, Cesarman E, Spina M, et al. HIV-associated lymphomas and gamma-herpesviruses. Blood 2009; 113: 1213-24.
20. Carbone A, Tirelli U, Gloghini A, et al. Human immunodeficiency virus-associated systemic lymphomas may be subdivided into two main groups according to Epstein-Barr viral latent gene expression. J Clin Oncol 1993; 11: 1674-81.
21. IARC. Hepatitis viruses. IARC Mongr. Eval. Carcinog. Risks Hum 1994; 59: 1-255.
22. Raza SA, Clifford GM, Franceschi S,. Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. Br J Cancer 2007; 96: 1127-34.
23. Ganem D, Prince AM,. Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 2004; 350: 1118-29.
24. De Villiers EM, Fauquet C, Broker TR, et al. Classification of papillomaviruses. Virology 2004; 324: 17-27.
25. Cogliano V, Baan R, Straif K, et al. Carcinogenicity of human papillomaviruses. Lancet Oncol 2005; 6: 204.
26. Muñoz N, Bosch FX, de Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-27.
27. Sitas F, Carrara H, Beral V, et al. Antibodies against human herpesvirus 8 in black South African patients with cancer. N Engl J Med 1999; 340: 1863-71.
28. Kazakov DV, Prinz BM, Michaelis S, et al. Study of HHV-8 DNA sequences in archival biopsies from lesional skin of Kaposi's sarcoma, various mesenchymal tumors and related reactive conditions. J Cutan Pathol 2002; 29: 279-81.
29. Lazzi S, Bellan C, Amato T, et al. Kaposi's sarcoma associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas? Hum Pathol 2006; 37: 23-31.
30. Lazzi S, Ferrari F, Nyongo A, et al. HIV-associated malignant lymphomas in Kenya (Equatorial Africa). Hum Pathol 1998; 29: 1285-89.
31. De Sanjose S, Goedert JJ, Marshall V, eet al. Risk of malignant lymphoma associated with human herpesvirus- 8: a case-control study in Spain. Br J Cancer 2004; 90: 2145-48.
32. Chaturvedi AK, Pfeiffer RM, Chang L, et al. Elevated risk of lung cancer among people with AIDS. AIDS 2007; 21: 207-13.
33. Patel P, Hanson DL, Sullivan PS, et al. Adult and adolescent spectrum of disease project and HIV outpatient study investigators. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 2008; 148: 728-36.
34. Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 2005; 97: 425-32.
35. Serraino D, Piselli P, Busnach G, et al. Immunosuppression and Cancer Study Group. Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe. Eur J Cancer 2007; 43: 2117-23.
36. Thio CL, Seaberg EC, Skolasky R, Jr, et al. Multicenter AIDS Cohort Study. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 2002; 360: 1921-26.
37. Kramer JR, Giordano TP, Souchek J, et al. The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C. Am J Gastroenterol 2005; 100: 56-63.
38. Bodaghi S, Yamanegi K, Xiao SY, et al. Colorectal papillomavirus infection in patients with colorectal cancer. Clin Cancer Res 2005; 11: 2862-67.
39. Damin DC, Caetano MB, Rosito MA, et al. Evidence for an association of human papillomavirus infection and colorectal cancer. Eur J Surg Oncol 2007; 33: 569-74.
40. Hennig EM, Suo Z, Thoresen S, et al. Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III). Breast Cancer Res Treat 1999; 53: 121-35.
41. Zur Hausen H,. The search for infectious causes of human cancers: where and why. Virology 2009; 392: 1-10.
42. Joshi D, Buehring GC,. Are viruses associated with human breast cancer? Scrutinizing the molecular evidence. Breast Cancer Res Treat 2012; 135: 1-15.
43. Pagano J, Blaser M, Buendia M, et al. Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol 2004; 14: 453-71.
44. Glaser SL, Hsu JL, Gulley ML,. Epstein Barr virus and breast cancer: state of the evidence for viral carcinogenesis. Cancer Epidemiol Biomarkers Prev 2004; 13: 688-97.
45. Angeloni A, Farina A, Gentile G, et al. Epstein Barr virus and breast cancer: search for antibodies to the novel BRF1 protein in sera of breast cancer patients. J Natl Cancer Inst 2001; 93: 560-1.
46. De Paoli P,. Epstein Barr virus: novel patented therapeutics. Exp Opin Ther Patents 2010; 20: 807-18.
47. Speck P, Long Necker R,. Infection of breast epithelial cells with Epstein Barr Virus via cell to cell contact. J Natl Cancer Inst 2000; 92: 1849-51.
48. Joshi D, Quadri M, Gangane N, et al. Association of Epstein Barr virus infection with breast cancer in rural indian women. PloS One 2009; 4: e8180.
49. Huang J, Chen H, Hutt-Fletcher RL, et al. Lytic viral replication as a contributor to the detection of Epstein Barr virus in breast cancer. J Virol 2003; 77: 13276-4.
50. Gaffey MJ, Frierson HF, Mills SE, et al. Medullary carcinoma of the breast: Identification of lymphocyte subpopulations and their significance. Mod Pathol 1993; 6: 721-8.
51. Labrecque LG, Barnes DM, Fentiman IS, et al. Epstein Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res 1995; 55: 39-45
52. Thorne LB, Ryan JL, Elmore SH, et al. Real time PCR measures Epstein Barr virus DNA in archival breast carcinomas. Diagn Mol Pathol 2005; 14: 29-33.
53. Bonnet M, Guinebretiere JM, Kremmer E, et al. Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst 1999; 91: 1376-81.
54. Arbach H, Viglasky V, Lefeu F, et al. Epstein-Barr virus (EBV) genome and expression in breast cancer tissue: effect of EBV infection of breast cancer cells on resistance to paclitaxel (Taxol). J Virol 2006; 80: 845-53.
55. Lorenzetti MA, De Matteo E, Gass H, et al. Characterization of Epstein Barr virus latency pattern in Argentine breast carcinoma. PLoS One 2010; 5: e13603.
56. McCall SA, Lichy JH, Bijwaard KE, et al. Epstein-Barr virus detection in ductal carcinoma of the breast. J Natl Cancer Inst 2001; 93: 148-50.
57. Fina F, Romain S, Ouaflick L, et al. Frequency and genome load of Epstein Barr virus in 509 breast cancers from different geographical areas. Br J Cancer 2001; 84: 783-90.
58. Lawson JS, Khan CJ, Iacopetta BJ, et al. Are some breast cancers sexually transmitted? Br J Cancer 2006; 95: 708.
59. Wang T, Chang P, Wang L, et al. The role of Human Papillomavirus infection in breast cancer. Med Oncol 2012; 29: 48-55
60. Khan NA, Castillo A, Koriyama C, et al. Human papillomavirus detected in females breast carcinomas in Japan. Br J Cancer 2008; 99: 408-14.
61. de Villiers EM, Sandstrom RE, zur Hausen H, et al. Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast. Breast Cancer Res 2005; 7: R1-11.
62. de Cremoux P, Thioux M, Lebigot I, et al. No evidence of human papillomavirus DNA sequences in invasive breast carcinoma. Breast Cancer Res Treat 2008; 109: 55-8.
63. Lindel K, Forster A, Altermatt HJ, et al. Breast cancer and human papillomavirus (HPV) infection: no evidence of a viral etiology in a group of Swiss women. Breast 2007; 16: 172-7.
64. Simões PW, Medeiros LR, Simões Pires PD, et al. Prevalence of human papillomavirus in breast cancer: a systematic review. Int J Gynecol Cancer 2012; 22: 343-7.
65. Strickler HD, Schiffman MH, Shah KV, et al. A survey of human papillomavirus 16 antibodies in patients with epithelial cancers. Eur J Cancer Prev 1998; 7: 305-13.
66. de Leõn DC, Montiel DP, Nemcova J, et al. Human papillomavirus (HPV) in breast tumors: prevalence in a group of Mexican patients. BMC Cancer 2009; 9: 26.
67. Liu Y, Chen JJ, Gao Q, et al. Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells. J Virol 1999; 73: 7297-307.
68. Indik S, Gunzburg WH, Salmons B, et al. Mouse mammary tumor virus infects human cells. Cancer Res 2005; 65: 6651-9.
69. Callahan R, Simith GH,. MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways. Oncogene 2000; 19: 992-1001.
70. Mason AL, Gilady S, Mackey JR,. Mouse Mammary Tumor Virus in Human Breast Cancer. Red Herring or Smoking Gun? Am J Pathol 2011; 179: 1588-90.
71. Park DJ, Southey M, Giles GG, et al. No evidence of MMTV-like env sequences in specimens from the Australian Breast cancer Family Study. Breast Cancer Res Treat 2011; 125: 229-235.
72. Glenn WK, Salmons B, Lawson JS, et al. Mouse mammary tumor-like virus and human breast cancer. Breast Cancer Res Treat 2010; 123: 907.
73. Lawson JS, Glenn W, Salmons B, et al. Mouse Mammary Tumor Virus-like Sequences in Human Breast Cancer. Cancer Res 2010; 70: 3576-85.
74. Mazzanti C, Al Hamad M, Fanelli G, et al. A mouse mammary tumor virus env-like exogenous sequence is strictly related to progression of human sporadic breast carcinoma. Am J Pathol 2011; 179; 2083-90.
75. MesaTejada R, Keydar I, Ramanarayanan M, et al. Detection in human breast carcinomas of an antigen immunologically related to a group specific antigen of mouse mammary tumor virus. Proc Natl Acad Sci USA 1978; 75: 1529-33.
76. Faschinger A, Rouault F, Sollner J, et al. Mouse mammary tumor virus integration site selection in human and mouse genomes. J Virol 2008; 82: 1360-7.
77. Yu Y, Morimoto T, Sasa M, et al. Human papillomavirus 33 in breast cancer in Chinese. Breast Cancer 2000; 7: 33-6.
78. Yasmeen A, Bismar TA, Kandouz M, et al. E6/E7 of HPV 16 promotes cell invasion and metastasis of human breast cancer cells. Cell Cycle 2007; 6: 2038-42.
79. Katz E, Lareef M, Rassa JC, et al. MMTV Env encodes an ITAM responsible for transformation of mammary epithelial cells in three-dimensional culture. J Exp Med 2005; 201: 431-9.
80. Ford CE, Faedo M, Crouch R, et al. Progression from normal breast pathology to breast cancer is associated with mouse mammary tumor virus -like sequences in men and women. Cancer Res 2004; 64: 4755-9.
81. Burnett-Hartman AN, Newcomb P, Potter JD,. Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus. Cancer Epidemiol Biomarkers Prev 2008; 17: 2970-9.
82. Chuang LC, Chen HC, You SL, et al. Association between human papillomavirus and adenocarcinoma of rectum and recto-sigmoid junction: a cohort study of 10,612 women in Taiwan. Cancer Causes and Control 2010; 21: 2123-8.
83. Weinberg DS, Newschaffer CJ, Topham A,. Risk for colorectal cancer after gynecologic cancer. Ann Int Med 1999; 131: 189-193.
84. Burnett-Hartman AN, Newcomb PA, Schwartz SM, et al. No association between antibodies to sexually transmitted infections and colorectal hyperplastic polyps in men: Minnesota Cancer Prevention Research Unit Polyp Study. Cancer Epidemiol Biomarkers Prev 2012; 21: 1599-601.
85. Buyru N, Tezol A, Dalay N,. Coexistence of K-ras mutations and HPV infection in colon cancer. BMC Cancer 2006; 6: 115.
86. Orlando Perez L, Barbisan G, Ottino A, et al. Human Papillomavirus DNA and Oncogene Alterations in Colorectal Tumors. Pathol Oncol Res 2010; 16: 461-8.
87. Collins D, Hogan AM, Winter D,. Microbial and viral pathogens in colorectal cancer. Lancet Oncol 2011; 12: 504-12.
88. Gornick MC, Castellsague X, Sanchez G, et al. Human papillomavirus is not associated with colorectal cancer in a large international study. Cancer Causes Control 2010; 21: 737-43.
89. Baltzell K, Buehring GC, Krishamarty S, et al. Limited evidence of human papillomavirus in breast tissue using molecular in situ methods. Cancer 2012; 118: 1212-20
90. Kirgan D, Manalo P, Hall M, et al. Association of Human Papillomavirus and Colon neoplasms. Arch Surg 1990; 125: 862-5.
91. Cheng JY, Sheu LF, Meng CL, et al. Detection of human papillomavirus DNA in colorectal carcinomas by polymerase chain reaction. Gut 1995; 37: 87-90.
92. Ricciardiello L, Chang D, Laghi L, et al. Mad-1 is the Exclusive JC virus strain present in the human colon, and its transcriptional control region has a deleted 98-base pair sequence in colon cancer tissue. J Virol 2001; 75: 1996-2001.
93. Link A, Shin S, Nagasaka T, et al. JC Virus Mediates Invasion and Migration in Colorectal Metastasis. PloS One 2009; 4: e8146.
94. Laghi L, Randolph A, Chauhan DP, et al. JC virus DNA is present in the mucosa of the human colon and in colorectal cancers. Proc Natl Acad Sci USA 1999; 96: 7484-9.
95. Jung WT, Li MS, Goel A, et al. JC virus T-antigen expression in sporadic adenomatous polyps of the colon. Cancer 2008; 112: 1028-36.
96. Theodoropoulos G, Panoussopoulos D, Papaconstantinou I, et al. Assessment of JC polyoma virus in colon neoplasms. Dis Colon Rectum 2005; 48: 86-91.
97. Smeets SJ, Hesselink AT, Speel EJ, et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 2007; 121: 2465-72.
98. Snijders PJ, Heideman DA, Meijer CJ,. Methods for HPV detection in exfoliated cell and tissue specimens. APMIS 2010; 118: 520-8.
99. Lundstig A, Stattin P, Persson K, et al. No excess risk for colorectal cancer among subjects seropositive for JC polyomavirus. Int J Cancer 2007; 121: 1098-102.
100. Maginnis MS, Atwood WJ,. JC virus: an oncogenic virus in animals and humans? Semin Cancer Biol 2009; 19: 261-9.
101. Gomez Roman J, Martinez M, Fernandez S, et al. Epstein Barr Virus associated adenocarcinomas and squamous cell lung carcinomas. Mod Pathol 2009; 22: 530-37.
102. Chu P, Cerilli L, Chen Y, et al. Epstein Barr virus plays no role in the tumorigenesis of small-cell carcinoma of the lung. Mod Pathol 2004; 17: 158-64.
103. Brouchet L, Valmary S, Dahan M, et al. Detection of oncogenic virus genomes and gene products in lung carcinoma. Br J Cancer 2005; 92: 743-6.
104. Ngan RK, Yip TT, Cheng WW, et al. Circulating Epstein-Barr virus DNA in serum of patients with lymphoepithelioma-like carcinoma of the lung: a potential surrogate marker for monitoring disease. Clin Cancer Res 2002; 8: 986-94.
105. Han AJ, Xiong M, Zong YS,. Association of Epstein Barr Virus With Lymphoepithelioma-like Carcinoma of the Lung in Southern China. Am J Clin Pathol 2009; 114: 220-6.
106. Huber M, Pavlova B, Muhlberger H, et al. Detection of the Epstein Barr Virus in primary adenocarcinoma of the lung with Signet-ring cells. Virchow Arch 2002; 441: 25-30.
107. Wong MP, Chung LP, Yuen ST, et al. In situ detection of Epstein Barr virus in non-small cell lung carcinomas. J Pathol 1995; 177: 233-40.
108. Miyagi J, Kinjo T, Tsuhako K, et al. Extremely high Langerhans cell infiltration contributes to the favourable prognosis of HPV-infected squamous cell carcinoma and adenocarcinoma of the lung. Histopathology 2001; 38: 355-67.
109. Soini Y, Nuorva K, Kamel D, et al. Presence of human papillomavirus DNA and abnormal p53 protein accumulation in lung carcinoma. Thorax 1996; 51: 887-93.
110. Aguayo F, Castillo A, Koriyama C, et al. Human papillomavirus 16 is integrated in lung carcinomas: a study in Chile. Br J Cancer 2007; 97: 85-91.
111. Koshiol J, Rotunno M, Gillison M, et al. Assessment of human papillomavirus in lung tomor tissue. J Natl Cancer Inst 2011; 103: 501-7.
112. Cheng YW, Chiou HL, Sheu GT, et al. The association of human papillomavirus 16/18 iinfection with lung cancer among non smoking Taiwanese women. Cancer Res 2001; 61: 2799-803.
113. Wang J, Cheng J, Wu D, et al. Frequent FHIT gene loss of heterozigosity in human papillomavirus-infected non smoking female lung cancer in Taiwan. Cancer Lett 2006; 235: 18-25.
114. Cheng YW, Wu M, Wang J, et al. Human Papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation. Cancer Res 2007; 67: 10686-93.
115. Loyo M, Guerrero-Preston R, Brait M, et al. Quantitative detection of Mekel cell virus in human tissues and possible mode of transmission. Int J Cancer 2010; 126: 2991-6.
116. Joh J, Bennet Jenson A, Moore G, et al. Human papillomavirus(HPV) and Merkel cell polyomavirus (MCPyV) in non small cell lung cancer. Exp Mol Pathol 2010; 89: 222-6.
117. Gheit T, Munoz J, Levican J, et al. Merkel cell polyomavirus in non-small cell lung carcinomas from Chile. Exp Mol Pathol 2012; 93: 162-6.
118. Helmbold P, Lahtz C, Herpel E, et al. Frequent hypermethylation of RASSF1A tumor suppressor gene promoter and presence of Mekel cell polyomavirus in small cell lung cancer. Eur J Cancer 2009; 45: 2207-21.
119. Klein F, Kotb W, Petersen I,. Incidence of human papillomavirus in lung cancer. Lung Cancer 2009; 65: 13-8.
120. Prabhu P, Jakalekshmi D, Pillai R,. Lung cancer and human papilloma viruses (HPVs): examining the molecular evidence. J Oncol 2012; 2012: 750270.
121. Thomas P, De Lamballerie X, Garbe L, et al. Detection of human papillomavirus DNA in primary lung carcinoma by PCR in primary lung carcinoma. Bull Cancer 1996; 83: 842-6.
122. Gorgoulis VG, Zacharatos P, Kotsinas A, et al. Human papillomavirus is possibly involved in laryngeal but not in lung carcinogenesis. Hum Pathol 1999; 30: 274-83.
123. Papadopolou K, Lambropoulou V, Davaris P, et al. Detection of human papillomaviruses in squamous cell carcinomas of the lung. Virchov Arch 1998; 433: 49-5.
124. Tsuhaho K, Nakazato I, Hirayatsu T, et al. Human papillomavirus DNA in adenosquamous carcinoma of the lung. J Clin Pathol 1998; 51: 741-9.
125. Kulski JK, Demeter T, Mutavzdic S, et al. Survey of histologic specimens of human cancer for human papilloma type 6/11/16/18 by filter in situ hybridization. Am J Clin Pathol 1990; 94: 566-70.
126. Bichakjian CK, Lowe L, Lao CD, et al. Merkel cell carcinoma: critical review with guidelines for multidisciplinary management. Cancer 2007; 110: 1-12.
127. Brade L, Muller-Lantzsch N, zur Hausen H,. Blymphotropic papovavirus and possibility of infections in humans. J Med Virol 1981; 6: 301-8.
128. Ambinder RF,. Gammaherpesviruses and "Hit-and-Run" oncogenesis. Am J Pathol 2000; 156: 1-3.